Spectral AI (MDAI) Competitors $1.19 +0.05 (+4.39%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MDAI vs. VANI, HYPR, MGRM, NSPR, MODD, ECOR, LUCD, APT, MLSS, and APYXShould you be buying Spectral AI stock or one of its competitors? The main competitors of Spectral AI include Vivani Medical (VANI), Hyperfine (HYPR), Monogram Orthopaedics (MGRM), InspireMD (NSPR), Modular Medical (MODD), electroCore (ECOR), Lucid Diagnostics (LUCD), Alpha Pro Tech (APT), Milestone Scientific (MLSS), and Apyx Medical (APYX). These companies are all part of the "medical equipment" industry. Spectral AI vs. Vivani Medical Hyperfine Monogram Orthopaedics InspireMD Modular Medical electroCore Lucid Diagnostics Alpha Pro Tech Milestone Scientific Apyx Medical Spectral AI (NASDAQ:MDAI) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation, dividends and community ranking. Which has higher earnings & valuation, MDAI or VANI? Spectral AI has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpectral AI$27.26M0.81-$20.85M-$0.65-1.83Vivani MedicalN/AN/A-$25.65M-$0.45-2.98 Is MDAI or VANI more profitable? Vivani Medical has a net margin of 0.00% compared to Spectral AI's net margin of -40.78%. Spectral AI's return on equity of 0.00% beat Vivani Medical's return on equity.Company Net Margins Return on Equity Return on Assets Spectral AI-40.78% N/A -77.87% Vivani Medical N/A -102.42%-49.21% Do insiders and institutionals hold more shares of MDAI or VANI? 67.1% of Spectral AI shares are owned by institutional investors. Comparatively, 6.8% of Vivani Medical shares are owned by institutional investors. 56.7% of Spectral AI shares are owned by insiders. Comparatively, 44.3% of Vivani Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community favor MDAI or VANI? Spectral AI received 3 more outperform votes than Vivani Medical when rated by MarketBeat users. CompanyUnderperformOutperformSpectral AIOutperform Votes5100.00% Underperform VotesNo VotesVivani MedicalOutperform Votes2100.00% Underperform VotesNo Votes Which has more volatility & risk, MDAI or VANI? Spectral AI has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 3.2, meaning that its share price is 220% more volatile than the S&P 500. Does the media favor MDAI or VANI? In the previous week, Spectral AI had 2 more articles in the media than Vivani Medical. MarketBeat recorded 4 mentions for Spectral AI and 2 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 0.78 beat Spectral AI's score of 0.50 indicating that Vivani Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Spectral AI 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Vivani Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate MDAI or VANI? Spectral AI presently has a consensus price target of $4.50, suggesting a potential upside of 278.15%. Vivani Medical has a consensus price target of $3.00, suggesting a potential upside of 123.88%. Given Spectral AI's stronger consensus rating and higher possible upside, research analysts plainly believe Spectral AI is more favorable than Vivani Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Spectral AI 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25Vivani Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummarySpectral AI beats Vivani Medical on 12 of the 17 factors compared between the two stocks. Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Get Spectral AI News Delivered to You Automatically Sign up to receive the latest news and ratings for MDAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDAI vs. The Competition Export to ExcelMetricSpectral AISurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.12M$4.51B$5.38B$8.84BDividend YieldN/A36.80%5.13%4.09%P/E Ratio-1.8326.03105.1417.83Price / Sales0.8146.931,233.15158.41Price / CashN/A53.5740.4136.29Price / Book-5.175.947.096.50Net Income-$20.85M$13.99M$119.65M$226.22M7 Day Performance-15.00%3.27%2.25%4.03%1 Month Performance-7.03%4.64%-2.33%4.92%1 Year Performance-52.02%47.15%33.98%29.30% Spectral AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDAISpectral AI2.5715 of 5 stars$1.19+4.4%$4.50+278.2%-52.0%$22.12M$27.26M-1.8378VANIVivani Medical3.1031 of 5 stars$1.33+3.1%$3.00+125.6%+40.3%$78.79MN/A-2.9620HYPRHyperfine2.1039 of 5 stars$0.98+8.9%$1.43+46.1%-15.7%$70.85M$11.03M-1.71190High Trading VolumeMGRMMonogram Orthopaedics1.1652 of 5 stars$1.98-1.0%N/A-34.3%$67.93M$370,000.00-4.2128NSPRInspireMD2.4472 of 5 stars$2.58-2.3%$4.50+74.4%+10.9%$67.29M$6.20M-3.4450MODDModular Medical2.6548 of 5 stars$1.94-5.8%$5.00+157.7%+58.5%$67.07MN/A-3.0839News CoverageGap DownHigh Trading VolumeECORelectroCore0.6411 of 5 stars$9.92-0.2%N/A+100.5%$64.98M$16.03M-5.4250High Trading VolumeLUCDLucid Diagnostics3.01 of 5 stars$1.00flat$3.69+269.1%-24.9%$59.28M$2.43M-0.8870APTAlpha Pro TechN/A$5.38+2.7%N/A+15.6%$59.18M$61.23M14.54120MLSSMilestone Scientific2.3995 of 5 stars$0.71+4.4%$1.25+76.6%-0.1%$55.15M$9.83M-10.1130Analyst ForecastAPYXApyx Medical1.4212 of 5 stars$1.45+3.6%N/A-37.7%$54.58M$52.35M-1.75270Gap Up Related Companies and Tools Related Companies VANI Competitors HYPR Competitors MGRM Competitors NSPR Competitors MODD Competitors ECOR Competitors LUCD Competitors APT Competitors MLSS Competitors APYX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MDAI) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectral AI, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectral AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.